Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Drugs Ltd has announced the closure of its trading window for designated persons and insiders, in line with SEBI's Insider Trading Regulations. The closure typically restricts directors, key managerial personnel, and connected persons from trading in the company's shares. The specific reason and duration of the closure are not detailed in the announcement, but such closures are standard practice ahead of financial results or material corporate events. Shareholders can expect a forthcoming announcement, most likely quarterly or annual financial results.
This is a routine compliance disclosure and does not directly impact share price. It signals that the company may be preparing to announce financial results or other material information soon, which investors should watch for.